Castle Hook Partners LP Atreca, Inc. Transaction History

Castle Hook Partners LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$13.0 - $19.34 $1.22 Million - $1.82 Million	-93,954 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.03 - $17.09 $3.99 Million - $5.23 Million	-306,046 Reduced 76.51%	93,954 $1.52 Million
Q3 2020 Nov 13, 2020	BUY	$12.67 - $23.19 $5.07 Million - $9.28 Million	400,000 New	400,000 $5.59 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Castle Hook Partners LP, based on Form 13F filings with the SEC.

Stay updated on Castle Hook Partners LP with notifications on news.